Edit |   |
---|---|
Antigenic Specificity | DLL4, Human (Demcizumab biosimilar) |
Clone | Demcizumab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG2 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, FCM, IP, FuncS, IF, Neut, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human DLL4 Recombinant Antibody (Demcizumab). Demcizumab /d m s z maeb/ is a humanized monoclonal antibody which is used to treat patients with pancreatic cancer or non-small cell lung cancer. Demcizumab has completed phase 1 trials and is currently undergoing phase 2 trials. Demcizumab was developed by OncoMed Pharmaceuticals in collaboration with Celgene. |
Immunogen | n/a |
Other Names | Anti-DLL4 Recombinant Antibody, Research Grade Demcizumab, Anti-Human DLL4 Recombinant Antibody(Demcizumab), OMP-21M18, Antibody Drug Analogues, Monoclonal Antibody, YR1276, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1243262-17-0 |
Catalog # | YR1276 |
Price | please inquire |
Order / More Info | DLL4, Human (Demcizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |